China 2-Butyl-4-chloro-5-formylimidazole Factory

Our advantages are lessen charges,dynamic income team,specialized QC,sturdy factories,premium quality services for 2-Butyl-4-chloro-5-formylimidazole,CAS NO 83857-96-9,83857-96-9,Losartan intermediate,Losartan advance intermediate, We often concertrating on creating new creative solution to meet request from our customers everywhere in the planet. Sign up for us and let's make driving safer and funnier with each other!
2-Butyl-4-chloro-5-formylimidazole, We adopt advanced production equipment and technology, and perfect testing equipment and methods to ensure our product quality. With our high-level talents, scientific management, excellent teams, and attentive service, our goods are favored by domestic and foreign customers. With your support, we are going to build a better tomorrow!

Hot Products

  • Benserazide hydrochloride

    Benserazide hydrochloride

    Product Name:Benserazide hydrochloride
    Molecular Formula:C10H16ClN3O5
    Molecular Weight;293.7
    CAS Registry Number;14919-77-8
  • methyl 5-bromo-2-methyl-benzoate

    methyl 5-bromo-2-methyl-benzoate

    Product Name:methyl 5-bromo-2-methyl-benzoate
    Molecular Formula:C9H9BrO2
    Molecular Weight:229.07
    CAS Registry Number:79669-50-4
  • Isoxepac

    Isoxepac

    Name:Isoxepac
    Molecular Formula:C16H12O4
    Molecular Weight:268.27
    CAS NO:55453-87-7
    Usage:Olopatadine Hydrochloride
  • Methyl propiolate

    Methyl propiolate

    Product Name:Methyl propiolate
    Molecular Formula:C4H4O2
    Molecular Weight:84.07
    CAS Registry Number:922-67-8
  • Blueberry extract

    Blueberry extract

    Product Name:Blueberry extract
    Molecular Formula:C27H31O16
    Molecular Weight;611.53
    CAS Registry Number;84082-34-8
  • Sorbitol

    Sorbitol

    Product Name:Sorbitol
    Molecular Formula:C6H14O6
    Molecular Weight:182.17
    CAS Registry Number:50-70-4

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept